Disrupting Cancer

Hear from the most brilliant minds on the front line in the fight against cancer.

With the discovery of the first gene therapy to be approved by the FDA, Penn Medicine is leading the world in immunotherapy research. Penn researchers are working relentlessly to realize the full potential of this innovative approach: reprogramming the body’s own immune cells to seek and destroy every last cancer cell.

Join PACT for a conversation with Carl June, leader of the team at Penn responsible for this historic CAR-T cell therapy. Dr. June was recently named one of Time Magazine's Most Influential People of 2018.

Learn how Dr. June and other Penn innovators are disrupting cancer right here in Philadelphia.

This program will feature a fireside chat with Carl June, interviewed by Osagie Imasogie, Senior Managing Partner, PIPV Capital, followed by a panel discussion featuring:

Aimee S. Payne, M.D., Ph.D. Albert M. Kligman Associate Professor of Dermatology, Penn Medicine

Steven Kelly President & CEO, CARMA Therapeutics

Usman “Oz” Azam President & CEO, Tmunity